Skip to content
Catalyst

3beta-hydroxyandrost-5-en-17-oneFinding

3beta-hydroxyandrost‑5-en‑17-one has no detected effect on Beck Depression Inventory (BDI) total score

no difference foundLimited evidenceFindingreplicated ×1

01 · The sentence it was drawn from

“A paired samples t test revealed that the Beck Depression Inventory (BDI) scores were not significantly different (p >.5) between the DHEA condition (M= 2.08, SD = 2.04) and the placebo condition (M = 2.63, SD = 2.93).”
Quoted verbatim from Administration of dehydroepiandrosterone (DHEA) enhances visual-spatial performance in postmenopausal women.
This finding among the 9 findings on its endpoint

3beta-hydroxyandrost-5-en-17-one

Beck Depression Inventory (BDI) total score

no difference found

Who
postmenopausal women aged 55-80 not using hormone replacement therapy, DHEA versus lactose placebo crossover with a 1-week washout
Dose studied
50 mg oral DHEA daily (capsules compounded by Belmar Pharmaceutical) for one 4-week period

Limited evidencePMID 21942436 · 2011

02 · The study

Study
crossover
Duration
4 weeks

Evidence, by strength

  • strong
  • moderate
  • limitedthis finding
  • very limited
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M7GY9V9E487G28E4503SRJ88